Pendulum will need to produce stronger clinical evidence to maintain relevance as orally available pharmaceutical alternatives emerge
Individual responses also vary, with those having higher initial BMIs generally experiencing more substantial weight loss
Tirzepatide is another drug that doctors prescribe for Type 2 diabetes
Looking ahead: Economics, evidence, and the shape of future kidney care The market now hinges on three factors: durability of effect, pricing and policy, and adoption at scale in people with T2D and CKD
Interactive clinical analysis, tap to animate concentration and pricing
Sample size calculation The primary hypothesis is that at the 6-month follow-up, the GLP-1RA group will have a mean FTND score reduction of approximately 2 points compared with the control group